At a glance
ClinicalIndex Comparison RecordN/ACompleted· 31 enrolled
Drug / intervention
Nasogastroduodenal Protocol +2 moredietary
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.
Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.
Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment
In Brief
A clinical study evaluating Nasogastroduodenal Protocol, Control, and 1 other intervention for Obesity and 6 related conditions. Completed, enrolled 31 participants across 1 site.
Detailed Summary
Medical Supervised Duodenal-Enteral Feeding for Overweight, Obesity and Increased Body Fat Percentage Treatment based on an intervention procedure performed by a Licensed Nutritionist Doctor for weight loss and loss of fat percentage in patients who need it.
Study Details
Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsObesity, Obesity, Visceral, Overweight and Obesity, Body Fat Disorder, Feeding and Eating Disorders, Hormone Disturbance, Weight Loss
CountriesColombia
CollaboratorsUniversity of Alicante, Universidad Miguel Hernandez de Elche
Timeline
N/ACompletedFinished
201820192020202120222023202420252026
Enrollment StartAug 2017
First PostedMay 2018
Primary CompletionDec 2018
Study CompletionJan 2019
TodayJul 2026
First PostedMay 31, 2018
Enrollment StartAug 3, 2017
Primary CompletionDec 23, 2018
Study CompletionJan 4, 2019
TodayJul 2, 2026
Enrollment to primary: 1.4 yearsPosted 8.1 years ago
Interventions
Nasogastroduodenal Protocoldietary
Complete nutrition (carbohydrates, lipids, proteins, vitamins, oligoelements)
Controlother
Progress registration of body composition values
Data analysisother
Statistical analysis of all data